HIBISTAT (CHLORHEXIDINE GLUCONATE) — FDA Approval NDA018300 (MOLNLYCKE HLTH)
HIBISTAT (CHLORHEXIDINE GLUCONATE) — FDA Approval NDA018300 (MOLNLYCKE HLTH) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: HIBISTAT; Active ingredients: CHLORHEXIDINE GLUCONATE; Application number: NDA018300.
| Brand name | HIBISTAT |
|---|---|
| Active ingredients | CHLORHEXIDINE GLUCONATE |
| Application number | NDA018300 |
| Sponsor | MOLNLYCKE HLTH |
| Dosage form | SOLUTION |
| Route | TOPICAL |
| Marketing status | Over-the-counter |
| Products in application | 1 |
| First approval date | 19800523 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →